chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Medication Erroe:       First Dose was Moderna.  Second dose was Pfizer.    No Adverse  Reaction Noted or Reported
Savier Chills and Shaking - Tempreture 101.9 at 7 AM 04/10
About 2-3 hours after the shot, I had tingle in left hand, chills, joint pain, nausea. Later I had fever and vomiting. Next morning 102+ temperature, fatigue, flu-like symptoms, etc. On third day, I was able to walk at 4PM some but still very ill and had cloudy urine.  By day four called Primary care and went in by 11:30AM and they did a physical and urine test. Urine test came back as positive for E. Coli infection. Antibiotics and Prednisone for the course of 5 days was prescribed. After a couple of days, I felt much recovered.
11FEB97 upper lt arm warm to touch, red, hard no fever, hurts, swollen 2x size, quote o mom;saw MD ordered moist warm compresses;MD felt is was an allerg rxn to vax;18FEB mom states sx are completely gone;
1st Dose: 2 ddays after gettng the dose, I would haave nausae, dizziness, severe stomach aches from 1:30 pm until 10 p.m at night During that time period not only did my stomach hurt but it would cause me to have IBS episodes where i had to go to the bathroom frequenty and h I had severe abdominal pain likeI usully have with IBS. Alo, my left arm would hurt very much . It was swollen and I could barely moe it or rase it up higher than 6 inches.  After 2 weeks and 2 days of this, the stomach ache, IS pain, and the upper left arm pain went away.  During the first week after getting the vaccine, I developed symptoms similar to getting covide that I calledthe Clinic. They said that I need to get a covid test and stay home. I got the covid test that day and stayed home for 2 days. After I had a negative test, I could go back to work. The nurse for the covid triage said that I should meet with my doctor . I was scheduled to see my doctor but my appointment with her wasn't scheduled until April 29, 2021. By then, all of the systems from the 1st cshot went away and I cancelled my appointment.
Pt developed significant swelling of (L) arm sternum, shoulder, (L) upper back. On exam, arm was swollen, (L) sternum still prominent and red hive seen on back. Responded to PO Benadryl. No fever.
Small raised "keloid like" scar to lower portion of deltoid on right arm within hours of administration.  No other symptoms.
Patient states that 3 days after she received the Pfizer vaccine she started a mentrual cycle.  When she came back to the pharmacy three weeks later she stated she was still having her menstrual cycle, and the bleeding was very irregular, sometimes clotty.   She said she had just finished her menstrual cycle before receiving the first dose so shouldn't have had a cycle, and that also she was always very regular with her cycles prior to this.
Patient reported that within 5 minutes of getting the injection, she got a sudden headache that lasted 10 minutes. About 10-20 minutes after the headache, she developed bilateral ringing in her ears and ear pain. This also lasted about 10 minutes and then resolved. She continues to have a mild/trace headache 2 hours after injection and feels tired.  Via phone call, Advised patient to hydrate, rest, and monitor symptoms. Advised to take Tylenol PRN for continued headache. Advised to call back if symptoms persist after 24 hours
Severely immunocompromised patient due for booster who presented to ED and subsequently admitted with GI and respiratory distress.  Provider discharge note below:  "Brief Summary of Hospital Stay:  Patient is a 53 yo male with history of alcoholic cirrhosis and hepatocellular carcinoma, hemorrhoids who presented with fever and hematochezia and found with acute anemia with Hgb 5.8. Patient was given 2U pRBC with improvement. GI was consulted who recommended ceftriaxone, octreotide and IV protonix due to concern for SBP. These were stopped by discharge following a steady clinical course and paracentesis inconsistent with SBP. Rectal bleeding was suspected to be from diverticulosis and/or hemorrhoids. Patient discharged in stable and improved condition with instructions to follow-up for outpatient colonoscopy and repeat paracentesis.   Patient was noted to be COVID-19 positive on admission despite being vaccinated March/April 2021 and acquiring and recovering from COVID-19 itself in 12/2021. Patient did not show any signs of acute COVID-19 symptoms while inpatient and he was instructed to get a colonoscopy once deemed safe by GI.   He was prescribed iron supplementation for his iron deficiency anemia and Anusol rectal cream for his hemorrhoids on discharge.   He was recommended to have IR outpatient perform a repeat paracentesis but with cytology on discharge."
I had the first dose of the Shingrix vaccine. I was not told that the next day I would have pain so bad in my right shoulder that I could barely move my arm. I remain in a lot of pain 2 days after the shot. The pain makes it difficult to sleep or to function.
My eyelids became very swollen and pink. Then under my eyes became swollen and pink.
RASH; MUSCLE SORENESS; TIREDNESS; HEADACHE; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced skin rash. On 02-APR-2021, the subject experienced muscle soreness. On 02-APR-2021, the subject experienced tiredness. On 02-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from skin rash, muscle soreness, tiredness, and headache on 03-APR-2021. This report was non-serious.
Inflammation, redness in neck and right side of face particularly nose, right eye. Slight itching and bumps. A lot of swelling at rt. eye. Went to PCP 10/29, put on course of prednisone. Sx clearing as of today (11/3/14). Rash started on rt arm when I went to see PCP, now clear.
This spontaneous report as received from a physician via company representative, refers to a 68 year old male patient. On an unknown date the patient was vaccinated with ZOSTAVAX (route, lot number, expiration date, strength and dose not reported). No other relevant medical history and no concomitant medications were reported. The reproter stated that two weeks after being vaccinated with ZOSTAVAX, the patient returned to the office and was diagnosed with "shingles". No other specific symptoms were provided. The reproter also stated that the patient did not have any immune system conditions prior to the administration of the ZOSTAVAX. The outcome of the shingles was reported as recovered/resolved. No further relevant information was provided. Additional information is not expected.
2/8- 0300 Temperature of 99.1, nausea, body aches. 2/8- 0600 Temperature of 100.4, nausea, body aches. (Tylenol 1000mg taken every 6 hours, Ibuprofen 400mg taken every 6 hours) 2/8- 2000 itching rash on both upper arms, took Benadryl and rash went away. 2/9- 0800 itching rash came back on upper arms, calves and ankles 2/9- 1000 appointment with virtual doctor and they prescribed over the counter Zyrtec, took Zyrtecp and rash went away after about 1 hour
Initially, patient was fussy and less interactive for about 1 week after her shots. She cried more and had poor eye contact. Then she developed seizures by 9/21. She was hospitalized on 10/1 for infantile spasms. 10/19/07 Reviewed vax record which confirms RO dose & lot # as reported.  11/16/07 Reviewed hospital ER medical records of 9/29/07 which reveal patient experienced continued myoclonus activity after being on antiseizure meds x few days.  D/C to home to f/u w/pcp & neuro.  11/27/07 Reviewed hospital medical records which reveal patient had initial seizure on 9/22/07 after being irritable x 1 day.  Seen at outlying ER where she was diagnosed w/mycoplasma pneumonia & tx w/antibiotics x 5 days.  Seen by pcp after that & referred to neurologist who read EEG as hypsarrhythmia & MRI as WNL.  Started antiseizure meds.  Continued to have bursts of seizure activity & pcp referred to hospital for ped neuro consult.  Admitted 10/1-10/9/2007.  Tx w/IVIG, antiseizure meds. FINAL DX: no d/c summary available, admit & d/c dates obtained verbally.  Admit dx: new onset encephalopathy & possible infantile spasm; recent mycoplasma pneumonia. Per 60 day follow up: Patient suffered infantile spasms from this event. Not sure if it was directly linked to vaccines, but the pediatric neurlogist fit it was.
Only side effect was on day 21 was HA and chills lasting one day and on day 22 was ST lasting one day.
patient was hospitalized after experiencing chest discomfort after receiving the 2nd dose of the Pfizer COVID Vaccine; This is a spontaneous report received from a contactable consumer (reporter's grandson) via Medical Information Team. A 20-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Not reported), via an unspecified route of administration on an unspecified date as 2nd dose, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 for COVID-19 Immunization. It was reported that, the patient was hospitalized after experiencing chest discomfort on an unspecified date after receiving the 2nd dose of the Pfizer COVID Vaccine. The seriousness of the event was reported as hospitalization. The outcome of the event was reported as unknown.
9 months ago, I received the shingles vaccine at my doctor's office. I have had pain at the site & a lump there & pain radiating up & down that arm.
Swollen lymph nodes near collar bone on side of injection and latent subcutaneous allergic reaction resulting in large, hard lump, redness, pain and itching at and around injection site.
I developed internal trembling or vibration sensation. Primarily in my head. Sometimes arms or hands. By end of november they did a whole bunch of bloodwork tests on me and everything was normal. I have a referral now to a neurologist.
Client received Pfizer booster at approximately 1455 Client alerted nurse she was feeling palpitations while sitting in the observation area. She stated she wanted her vital signs to be taken. Client was AAOx3 and was breathing normally. Client denied shortness of breath or difficulty breathing. No hives or redness observed on client arms, neck or face. Client stated she had received Janssen as her first dose but had no reactions to the vaccine. Client vital signs were taken by EMT  1500 BP 140/80 HR 76 RR 14 PUPILS PERLA within normal limits. Client sat in gravity chair without assistance.  Client stated she was feeling ?like a pounding feeling in her chest all the way to her ears?. At 1507 Auscultation of heart was done by EMT and confirmed palpitations every 3-5 secs. Client stated she had no medical conditions except for gastritis and takes some meds for it. She stated she had no allergies. She stated she only feels out breath when she?s in a hurry when busy. But no history of palpitations. Client stated she felt chest pressure and felt ?shaky?. 1510 BP 130/82 HR 78 with palpitations. At 1516 EMS was called for further assessment of client. Client?s Husband informed RN that two years ago an Arrythmia had been confirmed to patient, but no further follow-up was done. Client was very shaky due to being anxious about the situation and was being guided to have controlled breathing with Student nurse.. At Approximately 1525 EMS arrived at vaccination site and took over client?s care. AT 1539 Client walked with assistance by paramedics to the EMS truck. Client was taken to hospital.
Coughing up his lungs two days after his second injection.  Hes still doing it today; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: Ew0176, Expiry date: unknown) (age at the time of vaccination was 55 years), administered in Arm Left on 11May2021 at 15:30 as dose 2, single for COVID-19 immunization. The patient's medical history included pulmonary embolism. The patient's concomitant medication was not reported. The patient did not take any other vaccine in four weeks prior COVID -19 vaccine. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: Ew0151), via an unspecified route of administration, via unspecified route on 20Apr2021 at 15:30 as dose 1, single for COVID-19 immunization. On 13May2021 at 05:00, the patient started coughing up his lungs. The patient was still doing it today. No treatment received. The outcome of the event was not resolved.  Follow-Up (01Jul2021): Follow-up attempts were completed. No further information was expected.
Breakthrough COVID case. Onset was Wed. October 5.  Felt like a respiratory infection that escalated. I had severe ear pain, fatigue and body aches.  I received antibodies via stomach injections on Monday, Oct 11th in the evening. Starting feeling better 24-48 hours after treatment.
She came into the pharmacy and stated that her right arm was swollen, red and itchy for at least 3 days following the vaccination and was getting larger. She did not have any fever, did not use ice or take any medications and did not make a MD office visit.
Pain at injection site that radiated to the hand. Pain turned into numbness and heaviness. Pain then radiated to the neck and forehead. Pain then traveled down the the left leg. Increased pain for headache. Vital signs stable. Symptoms onset 30 min post vaccination. Tylenol at 45 min post vaccination with no improvement. Patient was transported via ambulance to local hospital.
Some of the middle toes on right foot became red and inflamed. The worst toe was the middle toe.; Middle toe, it was very, very, itchy; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 18Mar2021 at 08:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included high blood pressure, obesity and idiopathic urticaria. The patient reported that she had no food allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline hydrochloride (ZOLOFT) from an unknown date for an unknown indication and unknown if ongoing and hydrochlorothiazide (HCTZ) from an unknown date for an unknown indication and unknown if ongoing. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the right arm on 25Feb2021 at 08:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 25Mar2021, about seven days after the second dose, the patient reported that some of the middle toes on her right foot became red and inflamed. The worst toe was the middle toe which was very, very, itchy and inflamed and looked as if it might develop into an open sore. The patient considered going to a local walk-in clinic, but decided to wait it out.  The patient reported that after checking the web, the toes looked similar to chilblains. The patient reported that the toes had gradually gotten better over time and they were no longer itchy, but the middle toe still had some residual redness. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events middle toes on right foot became red and inflamed and very itchy middle toe was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Covid did actually spread to additional person who had all 4 series of the COVID Vaccine; Covid did actually spread to additional person who had all 4 series of the COVID Vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Covid did actually spread to additional person who had all 4 series of the COVID Vaccine". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient reported small red spots on breasts. A little itchy. Not painful. Worsened with bra irritation.
103.5 high fever, not well controlled with TYLENOL or MOTRIN.  Fever lasted 15 hours ranging from 103.5 - 100.7.  No redness, no swelling, no fussiness.
Sudden extremely loud tinnitus and loss of hearing in left ear beginning at 9AM on 6/2.  Body aches and low grade temp beginning approximately 7AM.  At 4:00 PM tinnitus has reduced but hearing loss is still at 85-90%
INJECTION WAS GIVEN  AFTER TIME ALLOWED OF FIRST VIAL PUNCTURE
Patient began feeling hot and weak a couple minutes after vaccine was administered. EMS were called and while we waited her blood pressure was checked. It was 106/85.
child had the vaccines in the morning before 12 noon , and had generalised tonic clonis seizure lasted for more than 20 minutes   EMS was called by the parent   child was taken to the ER where  intubated to secure the airways in ER , Hospital course was 2 days ,
On September 25th, I noticed a sore throat. The next day, I started to feel feverish. I had a low grade fever. Over the next couple of days, my throat felt swollen. I had a lot of pressure on my chest due to congestion. I called my doctor. They told me to take a COVID-19 test. My home COVID-19 tests were negative. I went to the hospital and took a COVID-19 test there. It was also negative. I took over the counter medicine. A week later, it all went into my chest. I was coughing a lot. I called the doctor again. I explained my symptoms. They said it sounded like bronchitis, but they asked me to take another COVID-19 test. I did, and it came back negative. They prescribed an inhaler, antibiotics, and a cough syrup. I had cough for 3 weeks that slowly died away. The medication helped break up the mucus. The mucus was green.
Soreness, can barely move when washes up, started 20 days after vaccine administration.
12 hours of expected side effects (fever, aches, flu-like symptoms) followed by persistent and constant bilateral tinnitus.  Originally treated for ear infection (antibiotics), then with steroids and anti-histimine. No improvements
Menveo (2 vials) + administered 66 yo patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 66-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMXA9388, expiry date 31-MAY-2025) for prophylaxis.   On 29-AUG-2023, the patient received Menveo. On 29-AUG-2023, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: Menveo (2 vials) + administered 66 yo patient).  The outcome of the inappropriate age at vaccine administration was unknown.   Additional Information: GSK receipt date: 30-AUG-2023 The patient was working as nurse and teaching. The vaccine administration facility was the same as primary reporter.    The reporter did not consent to follow-up. 66 years old patient received Menveo (2 vials), which led to inappropriate age at vaccine administration.
Within 2 hours of injection patient reported to nurse that she just didn't feel good.  Has a headache, dry mouth and vision problems.  Within another half hour stated "It feels like I took a draw on a toke".  Reported on 102605 at 0910 that the headache wasn't gone until Sunday, "but I have a history of headaches."  Stated the other symptoms were gone by "later that evening" after injection.
LPN did not read card on mixed doses of Pfizer Covid Vaccine.  Dose had been left that was reconstituted on Friday and left over the weekend.  LPN grabbed the dose and did not read dilution card that was in container with vaccine.  Pharmacist contacted and instructed patient will need another dose.  (booster)
Got covid the next day; Sick; This is a spontaneous report received from contactable consumer (patient herself). A 66-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and lot number: EL1284) via intramuscular on 30Dec2020 at single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Patient received 1st dose of vaccine on 30Dec2020. Patient "caught COVID right after and didn't get the 2nd dose". She was due back to get the second dose of the vaccine on 20Jan2021. After she got the first dose of the vaccine she got COVID the next day. She heard she is supposed to wait 90 days till she is supposed to get the vaccine. She was not diagnosed with COVID till 02Feb2021 since she was sick and could not get into to get the test. Outcome of events was unknown.  No follow-up attempts are needed. No further information is expected.
Only liquid portion used; Only liquid portion used; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 12-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA771A, expiry date 31-JAN-2024) for prophylaxis.   On 20-MAR-2023, the patient received Menveo. On 20-MAR-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Only liquid portion used) and inappropriate dose of vaccine administered (Verbatim: Only liquid portion used). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 21-MAR-2023 The nurse informed that a patient accidentally received only the liquid portion of Menveo. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. The patient received only the liquid portion of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Complained of not feeling well; site sore and swollen, little itchy, heart racing. HR 100; BP 150/80 Right; EMT called. 9:50 HR 120; 9:55 BP 140/80 Right; 10:00 BP 144/82, HR 88. Oxygen mask on - feels faint. Heart rate up when ambulance arrived; transferred to ER via ambulance.
I had my first Covid vaccination on Saturday, January 16th. After waiting the obligatory 15 minutes and feeling no side effects, we left to drive back. It was then (about 25 minutes after the shot was received) that I started to feel tingling in my upper gum/lip area. It felt as if I often fo after dentist visit where I'd had Novocain. It lasted about 4 hours and that was the sum of my reactions.   The vaccination was Moderna Lot 041L20A which has been temporarily suspended.